Chane Graziano
CIK 1133234 · View on SEC EDGAR ↗
First SEC filing: Feb. 10, 2012 · Latest: Feb. 10, 2012
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 27, 2013 | HBIO | P | 60,000 | $5.00 | $300,000 | 3,105,150 Direct | +1.97% | Acquired | -81.0% (price as of 2026-08-20) |
| Sept. 16, 2010 | HBIO | P | 10,005 | $3.63 | $36,318 | 3,798,481 Direct | -0.26% | Disposed | -73.8% (price as of 2026-08-20) |
| Sept. 16, 2010 | HBIO | P | 10,005 | $3.63 | $36,318 | 3,798,481 Direct | +0.26% | Acquired | -73.8% (price as of 2026-08-20) |
| Sept. 15, 2010 | HBIO | P | 62,361 | $3.60 | $224,500 | 3,788,476 Direct | -1.62% | Disposed | -73.6% (price as of 2026-08-20) |
| Sept. 15, 2010 | HBIO | P | 62,361 | $3.60 | $224,500 | 3,788,476 Direct | +1.67% | Acquired | -73.6% (price as of 2026-08-20) |
| Sept. 14, 2010 | HBIO | P | 21,434 | $3.55 | $76,091 | 3,726,115 Direct | +0.58% | Acquired | -73.2% (price as of 2026-08-20) |
| Sept. 14, 2010 | HBIO | P | 21,434 | $3.55 | $76,091 | 3,726,115 Direct | +0.58% | Acquired | -73.2% (price as of 2026-08-20) |
| Sept. 13, 2010 | HBIO | P | 6,200 | $3.45 | $21,390 | 3,704,681 Direct | +0.17% | Acquired | -72.5% (price as of 2026-08-20) |
| Sept. 13, 2010 | HBIO | P | 6,200 | $3.45 | $21,390 | 3,704,681 Direct | +0.17% | Acquired | -72.5% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (400,000) | $3.18 | Aug. 12, 2013 | 400,000 | Disposed |
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.99 | Aug. 12, 2013 | 300,000 | Disposed |
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (300,000) | $4.28 | Aug. 12, 2013 | 300,000 | Disposed |
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (125,000) | $2.98 | Aug. 12, 2013 | 125,000 | Disposed |
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (50,289) | $3.57 | Aug. 12, 2013 | 50,289 | Disposed |
| July 25, 2013 | HBIO | Stock Option (right to buy) | Common Stock (125,000) | $4.01 | Aug. 12, 2013 | 125,000 | Disposed |
| Dec. 11, 2012 | HBIO | Stock Option (right to buy) | Common Stock, par value $0.01 per share (200,000) | $3.48 | April 8, 2013 | 200,000 | Disposed |
| June 1, 2012 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (201,153) | $3.57 | June 1, 2022 | 201,153 | Acquired |
| June 2, 2011 | HBIO | Stock Option (right to buy) | Common Stock, par value $0.01 per share (107,500) | $5.64 | June 2, 2021 | 107,500 | Acquired |
| May 21, 2009 | HBIO | Stock Option (Right to buy) | Common Stock, par value $0.01 per share (400,000) | $3.18 | May 21, 2019 | 400,000 | Acquired |
| Dec. 4, 2008 | HBIO | Stock Option (Right to buy) | Common Stock, par value $0.01 per share (300,000) | $1.99 | Dec. 4, 2018 | 300,000 | Disposed |
| May 1, 2007 | HBIO | Stock Option (right to buy) | Common Stock, par value $0.01 per share (300,000) | $5.57 | May 1, 2017 | 300,000 | Acquired |
| Aug. 9, 2006 | HBIO | Stock Option (right to buy) | Common Stock, par value $0.01 per share (300,000) | $4.28 | Aug. 9, 2016 | 300,000 | Acquired |
| May 25, 2005 | HBIO | Non-qualified Stock Option (right to buy) | Common Stock (125,000) | $2.98 | May 25, 2015 | 125,000 | Acquired |
| Aug. 4, 2004 | HBIO | Non-Qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (125,000) | $4.01 | Aug. 4, 2014 | 125,000 | Acquired |
| March 25, 2004 | HBIO | Incentive Stock Option (right to buy) | Common Stock, par value $0.01 per share (200,000) | $8.79 | March 25, 2014 | 200,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | $221,008 | — | — | — | — | — | $11,433 | $232,441 |
| 2012 | $602,000 | — | — | — | — | — | $33,629 | $1,377,512 |
| 2011 | $602,000 | — | — | — | — | — | $37,961 | $1,259,107 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.